Serono Laboratories Inc. regulatory update

Serono (Norwell, Mass.) submitted an NDA to the FDA for Serostim, a mammalian cell-derived recombinant human growth hormone, to treat AIDS wasting in adults (cachexia). Clinical trial data show the product has both anabolic (protein-building) and anti-catabolic (protein-sparing) effects, allowing patients to gain weight and lean body mass during treatment. ...